OECD about the competition issues in the distribution of pharma products – from February 2014

http://www.oecd.org/daf/competition/competition-distribution-pharmaceuticals.htm Key findings from the discussion include:Policy-makers and enforcers need to understand the distinctive economic features of the pharmaceuticals sector thoroughly to be able to intervene in this sector.Better enforcement of regulation and of competition law, more consumer information, and greater control over the incentives provided...

0
0

UPDATE. From the producer to the customer – is the shortest way the best way ? Considerations about the advertising and pharma industries.

UPDATE 4:In February 2014 the Romanian Government issued an Emergency Government Ordinance (EGO), no 2/2014, which extends the public service obligations to ensure the uninterrupted provision of drugs also to the manufacturers and their authorized importers.  In addition, EGO 2/2014 provides that for the drugs...

0
0